PreventionJune 16, 202610 min read

Mole Mapping and Total Body Photography: Who Actually Needs It

Mole mapping and total body photography promise earlier melanoma detection, but they are not for everyone. A Canadian family physician explains how the imaging works, who truly benefits, what the evidence shows, and what it costs in Ontario.

Maryam Sobhkhiz Sabet

Maryam Sobhkhiz Sabet

MD, Family Physician

Mole Mapping and Total Body Photography: Who Actually Needs It

As of June 16, 2026.

Mole mapping and total body photography (TBP) are marketed as a way to catch skin cancer before it spreads. For some people, that is accurate. For most people with a few ordinary moles, it is more imaging than they need. This guide explains what the technology does, who genuinely benefits, what the evidence shows, and what it costs in Canada. DermaDex is a Canadian healthtech company that connects patients to certified dermatologists and builds artificial intelligence (AI)-assisted tools for skin assessment, so we field this question often.

What is mole mapping and how does total body photography work?

Short answer: Mole mapping is a structured method of photographing your moles and comparing the images over time so a clinician can catch lesions that change. Total body photography (TBP) records standardized, high-resolution photos of your whole skin surface, while mole mapping often adds close-up dermoscopy of individual spots. Some clinics now use three-dimensional (3D) TBP systems and artificial intelligence (AI) software to flag lesions for review. The photos become a baseline. At follow-up, your clinician looks for new moles and changes in existing ones, which are the warning signs that matter most.

A typical session starts with overview photos taken from set angles and distances, so the same body region looks the same at every visit. Individual moles of interest are then captured with a dermoscope, a magnifier with polarized light that reveals patterns the naked eye misses. When clinics repeat dermoscopy on the same lesion over time, the technique is called sequential digital dermoscopy imaging (SDDI). The Canadian Dermatology Association (CDA) describes melanoma as the most dangerous common skin cancer, and the value of any imaging is that it makes subtle change visible before a tumor grows deep.

Who actually needs mole mapping or total body photography?

Short answer: Most people with a handful of stable moles do not need mole mapping. It is aimed at people at higher risk of melanoma: those with many moles (often more than 50), atypical or dysplastic moles, a personal or family history of melanoma, fair skin that burns easily, or a weakened immune system. The CDA and the American Academy of Dermatology (AAD) tie surveillance to risk, not to everyone. If you have one or two ordinary moles, a periodic skin check and self-exams usually serve you better than a full imaging program.

Risk is the deciding factor. Canadian access pressures also matter here: the Canadian Institute for Health Information (CIHI) tracks long wait times for many specialist procedures, so a documented photographic baseline that a family physician can compare over time has practical value when dermatology appointments are months apart. For a deeper look at the warning signs themselves, see our guide to the ABCDE melanoma warning signs.

Risk profile Typical approach
1 to a few stable, ordinary moles Self-exams plus periodic clinician skin check
Many moles (often 50+) or several atypical moles Discuss mole mapping or total body photography
Personal or family history of melanoma Surveillance imaging often recommended
Fair, sun-sensitive skin with heavy past sun damage Higher monitoring threshold; ask a clinician
Immunosuppression (for example, transplant patients) Closer surveillance, sometimes with imaging

Does mole mapping detect skin cancer?

Short answer: Mole mapping does not diagnose cancer by itself. It helps clinicians detect melanoma earlier by making change visible, which can lead to thinner, more treatable tumors at the time of removal. A 2021 systematic review of 14 studies (12,082 people) found that patients monitored with TBP trended toward thinner melanomas and a higher proportion of in-situ (very early) tumors. Diagnosis still requires a clinician to examine a suspicious lesion and, when needed, take a biopsy. Photography guides the decision; the laboratory confirms it. No image, AI tool, or app replaces that biopsy step.

The evidence is strongest in higher-risk groups. In the same systematic review, the number of moles that had to be removed to find one melanoma ranged from about 3 to 1 up to 14.3 to 1, and tracking worked better for new lesions than for moles that had been watched for a long time. More recent work continues to test newer hardware: a 2025 randomized clinical trial in JAMA Dermatology examined 3D total-body photography in patients at high risk for melanoma. The Centers for Disease Control and Prevention (CDC) notes that early detection matters because melanoma can spread to other parts of the body if it is not caught early.

How much does mole mapping cost in Canada, and does OHIP cover it?

Short answer: In Ontario, a referral-based visit to a dermatologist to assess a worrisome mole is an insured service under the Ontario Health Insurance Plan (OHIP). Elective mole mapping or total body photography for screening, especially for low-risk people, is generally not an insured service and is paid privately. Private sessions in Canada commonly run about CAD $150 to $400, depending on whether dermoscopy and AI analysis are included, with lower fees for follow-up imaging. Coverage varies by province and by why the imaging is ordered, so confirm the cost and any referral requirements before you book.

The split is usually between assessment and screening. If a family doctor refers you because a specific spot looks suspicious, the dermatologist visit and any biopsy are covered as medically necessary care. The photographic screening program itself, done for monitoring rather than to assess a known problem, is typically the out-of-pocket part.

Service Typical Canadian cost Usually covered by OHIP?
Referral visit to assess a suspicious mole No direct charge to patient Yes, when referred and medically necessary
Biopsy of a worrying lesion No direct charge to patient Yes, as medically necessary care
Elective mole mapping or TBP screening About CAD $150 to $400 per session Generally no, paid privately
Follow-up imaging session Often lower than the baseline fee Generally no, paid privately

How does mole mapping compare with a self-exam and a regular skin check?

Short answer: Self-exams, a clinician skin check, and mole mapping work together rather than competing. Monthly self-exams using the ABCDE rule (Asymmetry, Border, Color, Diameter, Evolving) catch obvious changes between visits. A clinician skin check adds trained eyes and dermoscopy. Mole mapping adds a photographic memory so subtle change is not missed across appointments, which matters most for people with many or atypical moles. For most Canadians, regular self-exams plus a periodic professional check are enough. Mapping is an added layer for higher-risk patients, not a replacement for looking at your own skin.

The AAD recommends checking your own skin regularly and knowing your ABCDEs. Use this checklist at home, and book an assessment if any mole meets one or more of these signs.

Letter Stands for What to look for
A Asymmetry One half does not match the other half
B Border Edges are irregular, ragged, or blurred
C Color More than one shade, or uneven color
D Diameter Larger than about 6 mm (a pencil eraser)
E Evolving Any change in size, shape, color, or symptoms

What are the limits and privacy considerations of mole mapping?

Short answer: Mole mapping has real limits. It can miss melanomas that arise between moles or on areas that are hard to photograph, and it can flag harmless spots that lead to extra biopsies. Image quality, body positioning, and software differences all affect results. Privacy matters too: skin photographs are sensitive health information. In Ontario, they fall under the Personal Health Information Protection Act (PHIPA), so ask any clinic how images are stored, who can access them, and whether data stays in Canada. Sun protection still prevents more skin cancer than any amount of imaging.

Prevention does the heavy lifting. The World Health Organization (WHO) links ultraviolet (UV) radiation to skin cancer risk, and the Public Health Agency of Canada offers practical sun safety guidance, including checking the UV index and covering up. Canadian summers carry high UV days even at northern latitudes, and reflected light off snow and water raises exposure in winter and spring. For more on daily protection, see our sun protection and UV index guide for Canada. Mapping tells you what changed; sun habits change the odds.

What else do people commonly ask about mole mapping?

Short answer: The questions below come up most often when patients weigh mole mapping. The quick version: mapping is a tracking tool, not a diagnosis; it is usually paid out of pocket in Ontario; it is most worthwhile for higher-risk people; and it supports earlier melanoma detection without replacing a biopsy. If you are unsure where you fall, a family physician or dermatologist can assess your personal risk and tell you whether photographic surveillance is likely to help you. Detailed answers to each common question follow below.

What is mole mapping and how is it done?

Mole mapping is a structured way to photograph and track your moles so changes show up over time. A clinician or trained photographer takes standardized total body photography (TBP) images of your skin from set angles and distances, often with a digital camera or a 3D imaging booth. Individual moles of interest are then captured up close with a dermoscope, a magnifier with polarized light. The images become your baseline. At follow-up, usually every 6 to 12 months for higher-risk patients, the new photos are compared with the old ones to spot new moles or changes in existing ones. Some clinics add AI software that flags suspicious lesions for a clinician to review, but a person still makes the final call.

How much does mole mapping cost in Ontario?

In Ontario, mole mapping is usually a private, out-of-pocket service rather than something covered by the Ontario Health Insurance Plan (OHIP). Prices vary by clinic and by what is included, but full body photography with dermoscopy commonly runs about CAD $150 to $400 per session, with lower fees for follow-up imaging. A visit to a dermatologist to assess a specific suspicious mole, made through a family doctor referral, is generally an insured OHIP service, and any biopsy of a worrying lesion is covered as medically necessary care. The screening photography itself is the part you typically pay for. Always confirm pricing, what the fee includes, and whether a referral is needed before you book.

Is it worth getting mole mapping?

For higher-risk people, mole mapping is often worth it; for most others, it is optional. The evidence is strongest in patients with many moles, atypical moles, a personal or family history of melanoma, or fair, sun-sensitive skin. In those groups, tracking images helps clinicians catch melanoma earlier and remove fewer harmless moles unnecessarily. If you have a handful of stable, ordinary moles, regular self-exams and a periodic clinician skin check usually give you most of the benefit at no extra cost. The honest answer depends on your personal risk. A family physician or dermatologist can estimate that risk and tell you whether photographic surveillance is likely to change what happens to your skin.

Does mole mapping detect cancer?

Mole mapping does not diagnose cancer on its own, but it helps detect melanoma earlier. By recording a baseline and comparing images over time, it makes change visible, and change is one of the clearest warning signs of melanoma. Studies in higher-risk patients link photographic monitoring with thinner, earlier-stage tumors at the time of removal. What mapping cannot do is confirm a diagnosis. Only a clinician examining the lesion, and a biopsy sent to a laboratory when needed, can tell whether a spot is cancer. Think of mole mapping as an early-warning system that points a clinician toward the right lesion, not as a test that returns a yes-or-no cancer result.

When should you see a clinician instead of relying on photos?

Short answer: See a clinician whenever a mole is new, changing, itching, bleeding, or simply different from your others, no matter what any image or app suggests. This article is general information, not a diagnosis, and mole mapping is a tracking tool rather than a verdict. A photographic baseline is useful, but a trained clinician examining the lesion, with a biopsy when needed, is what confirms or rules out skin cancer. If you are higher risk or unsure, do not wait for your next scheduled imaging session. You can reach our team for help connecting to a certified dermatologist, and you can read more about DermaDex and how we work.

Sources

Frequently Asked Questions

You might also like

Start Your Journey

Ready to Take Control of Your Skin Health?

Join Canadians who are already using DermaDex for instant skin analysis and access to certified dermatologists.

Free AI Analysis

No credit card required

HIPAA Compliant

Your data is secure

Instant Results

Get answers in seconds